GS1-144 cuts hot-flash frequency in Chinese phase 2
Among 276 randomized women, 30 mg twice daily reduced moderate-to-severe VMS by 1.41 episodes a day versus placebo at week 12.
The full briefing is in the app.
Among 276 randomized women, 30 mg twice daily reduced moderate-to-severe VMS by 1.41 episodes a day versus placebo at week 12.
The full briefing is in the app.